AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 73 filers reported holding AURA BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 10.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $30,323 | +33.7% | 4,011 | +38.8% | 0.00% | – |
| Q1 2024 | $22,687 | +10.3% | 2,890 | +24.5% | 0.00% | – |
| Q4 2023 | $20,573 | -1.2% | 2,322 | 0.0% | 0.00% | – |
| Q3 2023 | $20,828 | -36.1% | 2,322 | -12.1% | 0.00% | – |
| Q2 2023 | $32,616 | +23.3% | 2,641 | -7.4% | 0.00% | – |
| Q1 2023 | $26,457 | +11.7% | 2,851 | +26.4% | 0.00% | – |
| Q4 2022 | $23,689 | -42.2% | 2,256 | 0.0% | 0.00% | – |
| Q3 2022 | $41,000 | +241.7% | 2,256 | +161.7% | 0.00% | – |
| Q2 2022 | $12,000 | +9.1% | 862 | +71.7% | 0.00% | – |
| Q1 2022 | $11,000 | +37.5% | 502 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | – | 502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $22,981,584 | 6.86% |
| Decheng Capital LLC | 515,555 | $3,897,596 | 1.19% |
| Eventide Asset Management | 5,802,682 | $43,868,276 | 0.75% |
| Nantahala Capital Management | 1,270,035 | $9,601,465 | 0.56% |
| Matrix Capital Management Company, LP | 6,922,870 | $52,336,897 | 0.40% |
| Long Focus Capital Management, LLC | 1,057,188 | $7,992,341 | 0.31% |
| ADAR1 Capital Management, LLC | 203,237 | $1,536,472 | 0.29% |
| LEVIN CAPITAL STRATEGIES, L.P. | 327,466 | $2,475,643 | 0.26% |
| TBH Global Asset Management, LLC | 60,322 | $456,037 | 0.10% |
| Corton Capital Inc. | 25,184 | $190,391 | 0.10% |